GH logo

Guardant Health (GH)

Profile

Full Name

Guardant Health, Inc.

Ticker Symbol

GH

Exchange

NASDAQ

Sector

Healthcare

Industry

Diagnostics & Research

Country

United States

IPO

October 4, 2018

Indexes

Not included

Website

http://guardanthealth.com

Employees

1999

Key Details

Price

$38.19(-2.50%)

Market cap

$4.73B(Mid cap)

Last Dividend

-

TTM Dividend yield

-

Annual revenue

$739.02M(+31.04% YoY)

Annual EPS

-$3.56(+16.82% YoY)

PE ratio

-

Next earnings date

Aug 7, 2025

Next ex-dividend date

N/A

Next split date

N/A

Quick Search

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    See Full Chart & Historical Data

    Analyst ratings

    Price

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Current Price

    $38.19
    GH price is $38.19

    30-Day Relative Volume

    0.71
    GH 30-day relative volume is 0.71

    Price Performance

    Price Most recent change

    -2.5%
    GH price was down -2.5% on May 28, 2025

    Price YTD change

    +25.01%
    GH price is up +25.01% since January 1st

    Price 1-year change

    +46.38%
    GH price is up +46.38% year-on-year

    Price 3-year change

    -11.19%
    GH price is down -11.19% over the past 3 years

    Price Range

    Price All-time high

    $181.07
    GH price is currently -78.91% below its historical high of $181.07

    Price 3-year low

    $15.81
    GH price is currently +141.56% above its 3-year low

    Capitalization

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Market cap

    Market cap

    $4.73B
    GH market capitalization is $4.73 billion

    Market cap 3-year change

    +7.95%
    GH market capitalization is up +7.95% over the past 3 years

    Market cap All-time high

    $17.95B
    GH market capitalization is currently -73.64% below its historical high of $17.95 billion

    Market cap sector rank

    88.96%
    GH market capitalization is higher than 88.96% of companies in Healthcare sector

    Shares Outstanding

    Shares Outstanding 1-Year Change

    +1.24%
    GH shares outstanding is up +1.24% year-on-year

    Shares Outstanding 3-Year Change

    +21.55%
    GH shares outstanding is up +21.55% over the past 3 years

    Technical Indicators

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Beta

    1.29
    GH beta is 1.29

    200-day SMA

    $35.17
    GH price is currently +8.60% above its 200-day simple moving average

    50-day SMA

    $43.24
    GH price is currently -11.67% below its 50-day simple moving average

    RSI

    39.08
    GH 14-day relative strength index is 39.08

    Volume

    0.71
    GH 30-day relative volume is 0.71

    ATR

    $1.99
    GH average true range is $1.99

    10-day Historical Volatility

    45.27%
    GH 10-day historical volatility is 45.27%

    Dividend

    Income Statement

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Revenue

    Revenue

    $739.02M
    GH annual revenue is $739.02 million

    Revenue Analysts estimate

    $884.14M
    GH annual revenue is currently -16.41% lower than the consensus analysts' forecast

    Revenue 1-year change

    +31.04%
    GH annual revenue is up +31.04% year-on-year

    Revenue Sector rank

    77.98%
    GH annual revenue is higher than 77.98% of companies in Healthcare sector

    EPS

    EPS

    -$3.56
    GH annual earnings per share is -$3.56

    EPS Analysts estimate

    -$1.99
    GH annual earnings per share is currently +78.73% higher than the consensus analysts' forecast

    EPS 1-year change

    +16.82%
    GH annual earnings per share is up +16.82% year-on-year

    EPS Sector rank

    24.98%
    GH annual earnings per share is higher than 24.98% of companies in Healthcare sector

    Profit

    Gross profit

    $449.22M
    GH annual gross profit is $449.22 million

    Gross margin

    60.79%
    GH annual gross profit margin is 60.79%

    Operating profit

    -$443.59M
    GH annual operating income is -$443.59 million

    Operating margin

    -60.03%
    GH annual operating profit margin is -60.03%

    Net income

    -$436.37M
    GH annual net profit is -$436.37 million

    Net margin

    -59.05%
    GH annual net profit margin is -59.05%

    Expenses

    Total expenses

    $1.18B
    GH annual total expenses is $1.18 billion

    Operating expenses

    $892.81M
    GH annual total operating expenses is $892.81 million

    Cost of goods sold

    $289.80M
    GH annual cost of goods sold is $289.80 million

    Selling, general & administrative expenses

    $545.06M
    GH annual SGA is $545.06 million

    Depreciation and amortization

    $42.39M
    GH annual depreciation & amortization is $42.39 million

    Interest expense

    $2.58M
    GH annual interest expense is $2.58 million

    Income tax

    $1.28M
    GH annual income tax is $1.28 million

    EBIT & EBITDA

    EBIT

    -$432.51M
    GH annual earnings before interest & taxes is -$432.51 million

    EBITDA

    -$390.12M
    GH annual EBITDA is -$390.12 million

    Balance Sheet

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Assets

    Total assets

    $1.49B
    GH annual total assets is $1.49 billion

    Non current assets

    $430.50M
    GH annual long term assets is $430.50 million

    Current assets

    $1.06B
    GH annual total current assets is $1.06 billion

    Cash and cash equivalents

    $525.54M
    GH annual cash & cash equivalents is $525.54 million

    Accounts receivable

    $106.85M
    GH annual accounts receivable is $106.85 million

    Inventory

    $71.08M
    GH annual inventory is $71.08 million

    Liabilities

    Total liabilities

    $1.63B
    GH annual total liabilities is $1.63 billion

    Long term liabilities

    $1.40B
    GH annual total long term liabilities is $1.40 billion

    Current liabilities

    $225.58M
    GH annual total current liabilities is $225.58 million

    Accounts payable

    $38.55M
    GH annual accounts payable is $38.55 million

    Debt

    Total debt

    $1.34B
    GH annual total debt is $1.34 billion

    Total debt 1-year change

    -1.31%
    GH annual total debt is down -1.31% year-on-year

    Long term debt

    $1.31B
    GH annual long term debt is $1.31 billion

    Short term debt

    $29.21M
    GH annual short term debt is $29.21 million

    Equity & Capital

    Shareholders equity

    -$139.65M
    GH annual stockholders equity is -$139.65 million

    Book value

    -$139.65M
    GH annual book value is -$139.65 million

    Retained earnings

    -$2.58B
    GH annual retained earnings is -$2.58 billion

    Working capital

    $829.53M
    GH annual working capital is $829.53 million

    Cash Flow Statement

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Cashflow Activities

    Cash from operations

    -$239.86M
    GH annual cash flow from operations is -$239.86 million

    Cash from operations 1-year change

    +26.19%
    GH annual cash flow from operations is up +26.19% year-on-year

    Cash from investing

    -$261.31M
    GH annual cash flow from investing activities is -$261.31 million

    Cash from investing 1-year change

    -131.1%
    GH annual cash flow from investing activities is down -131.1% year-on-year

    Cash from financing

    -$996.00K
    GH annual cash flow from financing activities is -$996.00 thousand

    Cash from financing 1-year change

    -100.21%
    GH annual cash flow from financing activities is down -100.21% year-on-year

    CAPEX

    CAPEX

    $35.09M
    GH annual capital expenditures is $35.09 million

    CAPEX 1-year change

    +71.26%
    GH annual capital expenditures is up +71.26% year-on-year

    Free Cash Flow

    Free cash flow

    -$274.94M
    GH annual free cash flow is -$274.94 million

    Free cash flow 1-year change

    +20.41%
    GH annual free cash flow is up +20.41% year-on-year

    Profitability Ratios

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Margins

    Gross margin

    60.79%
    GH annual gross profit margin is 60.79%

    Operating margin

    -60.03%
    GH annual operating profit margin is -60.03%

    Net margin

    -59.05%
    GH annual net profit margin is -59.05%

    ROA & ROE

    ROA

    -26.67%
    GH annual return on assets is -26.67%

    ROE

    -4584.47%
    GH annual return on equity is -4584.47%

    Valuation

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    PE Ratio

    PE ratio

    -
    GH price to earnings ratio value is unknown

    PE ratio Sector rank

    -
    GH price to earnings ratio is unknown

    PB Ratio

    PB ratio

    -18.87
    GH price to book ratio is -18.87

    PB ratio Sector rank

    2.3%
    GH price to book ratio is higher than 2.3% of companies in Healthcare sector

    PS Ratio

    PS ratio

    6.11
    GH price to sales ratio is 6.11

    PS ratio Sector rank

    69.62%
    GH price to sales ratio is higher than 69.62% of companies in Healthcare sector

    Enterprise value

    Enterprise value

    $5.34B
    GH enterprise value is $5.34 billion

    Enterprise value Sector rank

    88.52%
    GH enterprise value is higher than 88.52% of companies in Healthcare sector

    EV/EBITDA

    EV/EBITDA

    -14.40
    GH EV/EBITDA is -14.40

    EV/EBITDA Sector rank

    8.81%
    GH EV/EBITDA is higher than 8.81% of companies in Healthcare sector

    Financial Health

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Liquidity

    Current ratio

    4.68
    GH annual current ratio is 4.68

    Quick ratio

    4.36
    GH annual quick ratio is 4.36

    Leverage

    Debt to equity

    -8.18
    GH annual debt to equity ratio is -8.18

    Interest coverage ratio

    -167.57
    GH annual interest coverage ratio is -167.57

    Risk & Stability

    Piotroski F-Score

    4
    GH piotroski f-score is 4

    Altman Z-Score

    -0.48
    GH altman z-score is -0.48

    Analyst ratings

    Recent major analysts updates

    May 6, 25 Piper Sandler
    Overweight
    May 5, 25 Scotiabank
    Sector Outperform
    May 1, 25 UBS
    Buy
    May 1, 25 TD Securities
    Buy
    May 1, 25 Stifel
    Buy
    May 1, 25 Canaccord Genuity
    Buy
    May 1, 25 Barclays
    Overweight
    Apr 10, 25 Mizuho
    Outperform
    Apr 10, 25 Barclays
    Overweight
    Mar 26, 25 Stephens & Co.
    Overweight

    Institutional Ownership

    Screeners with GH included

    Growing Shares Outstanding
    Mid cap stocks
    US stocks
    Stocks with high beta
    Most recommended stocks
    NASDAQ Dividend Calendar
    Stocks above SMA 50
    Stocks below analysts price target
    Healthcare sector
    All stocks
    • What is the ticker symbol for Guardant Health?
    • Does Guardant Health pay dividends?
    • What sector is Guardant Health in?
    • What industry is Guardant Health in?
    • What country is Guardant Health based in?
    • When did Guardant Health go public?
    • Is Guardant Health in the S&P 500?
    • Is Guardant Health in the NASDAQ 100?
    • Is Guardant Health in the Dow Jones?
    • When was Guardant Health's last earnings report?
    • When does Guardant Health report earnings?
    • Should I buy Guardant Health stock now?

    What is the ticker symbol for Guardant Health?

    The ticker symbol for Guardant Health is NASDAQ:GH

    Does Guardant Health pay dividends?

    No, Guardant Health does not pay dividends

    What sector is Guardant Health in?

    Guardant Health is in the Healthcare sector

    What industry is Guardant Health in?

    Guardant Health is in the Diagnostics & Research industry

    What country is Guardant Health based in?

    Guardant Health is headquartered in United States

    When did Guardant Health go public?

    Guardant Health's initial public offering (IPO) was on October 4, 2018

    Is Guardant Health in the S&P 500?

    No, Guardant Health is not included in the S&P 500 index

    Is Guardant Health in the NASDAQ 100?

    No, Guardant Health is not included in the NASDAQ 100 index

    Is Guardant Health in the Dow Jones?

    No, Guardant Health is not included in the Dow Jones index

    When was Guardant Health's last earnings report?

    Guardant Health's most recent earnings report was on Apr 30, 2025

    When does Guardant Health report earnings?

    The next expected earnings date for Guardant Health is Aug 7, 2025

    Should I buy Guardant Health stock now?

    As of today, analysts generally recommend a 'Buy' rating. However, it's important to do your own research and consider your financial situation before making any investment decisions
    On this page